About CTRL Therapeutics
CTRL Therapeutics operates a biotechnology company that researches cell therapy development and treatment. It is based in Toronto, Canada.
Company details
Funding
Total raised
$10M
Last stage
Seed
Investors
Founders
Shana Kelley
Ph.D. scientist and co-founder of CTRL Therapeutics; developed the proprietary microfluidic/magnetic cell-sorting platform (IsoQore) for isolating circulating tumor-reactive lymphocytes from blood; technology licensed from the University of Toronto.
LinkedInDerrell Porter
MD with over 20 years of biopharma experience; formerly founder and CEO of Cellevolve Bio; held leadership roles at Atara Bio, Gilead Sciences, AbbVie, Amgen, and McKinsey & Company; sits on the boards of Passage Bio and Acumen Pharma.
What happens next.
No applications, no recruiter spam. Just the intro.
Confirm the fit
A few questions to make sure this role is the right shape for you. Two minutes.
I pitch you to the company
I write the intro, send it to the founder, and handle the back-and-forth.
A meeting lands on your calendar
If they’re a yes, I book the chat. You show up — that’s the whole job-hunt.